A detailed history of Boston Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Boston Partners holds 1,213,160 shares of MRK stock, worth $118 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,213,160
Previous 1,221,091 0.65%
Holding current value
$118 Million
Previous $151 Million 8.87%
% of portfolio
0.17%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $881,530 - $1.02 Million
-7,931 Reduced 0.65%
1,213,160 $138 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $4.89 Million - $5.25 Million
-39,489 Reduced 3.13%
1,221,091 $151 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $3.93 Million - $4.58 Million
-34,684 Reduced 2.68%
1,260,580 $166 Million
Q4 2023

Feb 07, 2024

SELL
$100.18 - $109.02 $9.61 Million - $10.5 Million
-95,976 Reduced 6.9%
1,295,264 $141 Million
Q3 2023

Nov 07, 2023

SELL
$102.95 - $114.33 $5.45 Million - $6.05 Million
-52,937 Reduced 3.67%
1,391,240 $143 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $14.4 Million - $15.7 Million
-133,036 Reduced 8.43%
1,444,177 $167 Million
Q1 2023

May 09, 2023

SELL
$102.94 - $114.86 $3.74 Million - $4.17 Million
-36,290 Reduced 2.25%
1,577,213 $168 Million
Q4 2022

Feb 07, 2023

SELL
$87.44 - $112.11 $8.85 Million - $11.3 Million
-101,192 Reduced 5.9%
1,613,503 $179 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $8.62 Million - $9.68 Million
-101,950 Reduced 5.61%
1,714,695 $148 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $5.75 Million - $6.51 Million
-68,838 Reduced 3.65%
1,816,645 $166 Million
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $4.21 Million - $4.72 Million
-57,297 Reduced 2.95%
1,885,483 $155 Million
Q4 2021

Feb 04, 2022

SELL
$72.28 - $90.54 $61.2 Million - $76.7 Million
-846,752 Reduced 30.35%
1,942,780 $149 Million
Q3 2021

Nov 05, 2021

BUY
$71.68 - $78.83 $10.9 Million - $12 Million
151,945 Added 5.76%
2,789,532 $210 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $10.9 Million - $12.1 Million
155,564 Added 6.27%
2,637,587 $205 Million
Q1 2021

May 10, 2021

BUY
$68.86 - $81.11 $50.3 Million - $59.2 Million
730,354 Added 41.69%
2,482,023 $191 Million
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $219 Million - $244 Million
-3,057,918 Reduced 63.58%
1,751,669 $143 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $36.2 Million - $41.1 Million
-495,221 Reduced 9.34%
4,809,587 $399 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $79.5 Million - $90.4 Million
-1,128,343 Reduced 17.54%
5,304,808 $410 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $216 Million - $300 Million
3,415,065 Added 113.15%
6,433,151 $495 Million
Q4 2019

Feb 05, 2020

SELL
$77.58 - $87.54 $33.2 Million - $37.5 Million
-428,054 Reduced 12.42%
3,018,086 $275 Million
Q3 2019

Nov 20, 2019

SELL
$76.08 - $82.93 $13.6 Million - $14.8 Million
-178,495 Reduced 4.92%
3,446,140 $290 Million
Q3 2019

Nov 08, 2019

BUY
$76.08 - $82.93 $58,353 - $63,607
767 Added 0.02%
3,624,635 $304 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $12.6 Million - $14.7 Million
-180,447 Reduced 4.74%
3,623,868 $304 Million
Q1 2019

May 03, 2019

SELL
$69.58 - $79.36 $8.89 Million - $10.1 Million
-127,761 Reduced 3.25%
3,804,315 $316 Million
Q4 2018

Feb 07, 2019

SELL
$65.24 - $75.71 $619 Million - $718 Million
-9,482,253 Reduced 70.69%
3,932,076 $300 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $65.5 Million - $77 Million
-1,135,296 Reduced 7.8%
13,414,329 $952 Million
Q2 2018

Aug 03, 2018

SELL
$50.83 - $59.72 $18.9 Million - $22.2 Million
-372,072 Reduced 2.49%
14,549,625 $883 Million
Q1 2018

May 04, 2018

SELL
$50.96 - $59.23 $114 Million - $133 Million
-2,242,131 Reduced 13.06%
14,921,697 $813 Million
Q4 2017

Feb 01, 2018

SELL
$51.62 - $61.64 $80.9 Million - $96.6 Million
-1,567,046 Reduced 8.37%
17,163,828 $966 Million
Q3 2017

Nov 02, 2017

BUY
$58.67 - $63.13 $1.1 Billion - $1.18 Billion
18,730,874
18,730,874 $1.2 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.